Clinical Trial Management - Cognos

Synexus is at the forefront of innovation in the clinical trials industry so the introduction of the state-of-the-art Cognos system was a natural step to help provide unrivalled control of the entire study lifecycle.

The importance of effective clinical trial management cannot be overstated. Having the means to understand and predict the exact performance of a large phase III trial can be a daunting task. The IBM solution, developed in partnership with Synexus, has a number of far-reaching benefits including the ability to understand whether sufficient patient numbers have been forecast to meet study goals, whether patients are being enrolled quickly enough to meet end points, which Dedicated Research Centres are underperforming and whether there is an adequate balance between cost and performance for example. An IBM planning solution has also been put in place to allow modelling and tracking of clinical budgets and contract proposals. This provides powerful based forecasting and ‘what if' scenario modelling which is far more beneficial than rigid budgeting processes.

The clinical trials industry is recognised as one of the most complex and rapidly changing arenas in the healthcare market; the increasing complexity of studies, the rising awareness towards drug safety and an increasingly stringent regulatory environment, have all contributed towards escalating costs and underlined the urgent need for a new approach.